MCAC Panel Will Review PET Coverage For Dementia, Alzheimer’s Disease
This article was originally published in The Gray Sheet
Executive Summary
A technology assessment finding insufficient evidence to support coverage of FDG-PET for diagnosis and patient management of Alzheimer's disease and dementia will be weighed by the Medicare Coverage Advisory Commission Diagnostic Imaging Panel in Baltimore Jan. 10